サイクロプロペノン反応剤によって活性化されるオートホーナル・N・システイン特異タンパク質の改変のためのプラットフォーム
Alena Istrate1, Michael B Geeson1, Claudio D Navo2
1Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, CB2 1EW Cambridge, United Kingdom.
Journal of the American Chemical Society
|June 6, 2022
まとめ
新しいサイクロプロペノン (CPO) 反応剤は,タンパク質のN端システイン残基を選択的に修正する. このタンパク質結合戦略は,精密なバイオコンジュガート製造と治療開発を可能にします.
科学分野:
- 生物結合化学
- タンパク質工学
- 薬剤化学
背景:
- タンパク質結合体は 治療法や生物学的研究に不可欠です
- タンパク質の特定のアミノ酸残基の選択的改変は依然として大きな課題です.
- 既存の方法はしばしばタンパク質内の様々な反応部位を区別するのに苦労します.
研究 の 目的:
- N端のシステイン残基で選択的なタンパク質改変のための新しい方法を開発する.
- 標的生物結合のための多用途サイクロプロペノン (CPO) 反応剤を作成する.
- 複合タンパク質結合体とミミックの構築におけるCPO反応剤の有用性を実証する.
主な方法:
- N端のシステイン1,2-アミノチオール群との選択反応のために使用された単位置換サイクロプロペノン (CPO) 反応剤.
- 一般的な活性化エステルであるCPO-pentafluorophenol (CPO-PFP) から開発されたCPOベースの反応剤.
- CPO反応物の選択性メカニズムを明らかにするために量子力学的計算を使用した.
主要な成果:
- 安定した1,4-チアゼパン-5-アンの結合形成は,軽度な,生物互換性のある条件下で達成された.
- ペプチドとタンパク質のN端のシステインの選択的改変が示され,内部システインが存在する場合でも.
- デュアルラベルのタンパク質結合体 (2×cys-GFP) と,β-IL2受容体に対するナノモラー afinityの低いIL2のタンパク質模倣ダイマーを成功裏に準備した.
- CPO反応剤とディチオトリートール (DTT) の互換性が確認された.
結論:
- CPO反応剤は,タンパク質のN端のシステイン残基を標的とする強力な選択的方法を提供します.
- このアプローチにより,複雑な多ラベル生物結合体が精度が向上します.
- 策定された戦略は,タンパク質ベースの治療法と研究ツールの進歩に大きな可能性を秘めています.
関連する概念動画
Protein Modifications in the RER
5.7K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.7K
Nucleophilic Acyl Substitution of Carboxylic Acid Derivatives
3.6K
Nucleophilic acyl substitution is an important class of substitution reactions involving a nucleophile and an acyl compound, such as carboxylic acids and their derivatives. In these reactions, the leaving group attached to the acyl group is substituted by a nucleophile. The general mechanism proceeds via two steps.
3.6K
Covalently Linked Protein Regulators
7.5K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.5K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
474
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
474
Cycloaddition Reactions: Overview
2.9K
Cycloadditions are one of the most valuable and effective synthesis routes to form cyclic compounds. These are concerted pericyclic reactions between two unsaturated compounds resulting in a cyclic product with two new σ bonds formed at the expense of π bonds. The [4 + 2] cycloaddition, known as the Diels–Alder reaction, is the most common. The other example is a [2 + 2] cycloaddition.
2.9K


